Airsculpt Technologies is trading at $3.25 (+18.00%) with no new company-specific catalyst clearly explaining the rebound.
- Shares declined 45.11% on August 10 after disappointing quarterly results.
- Second-quarter revenue reached $42.9 million, below the $44.2 million consensus estimate.
- Management lowered full-year adjusted EBITDA guidance to $12 million-$14 million; volatility may reflect post-earnings trading.